NuCana is currently owned by Sofinnova Partners, through Sofinnova Capital VIII, since 2015.

When did Sofinnova Partners acquire NuCana?

Sofinnova Partners acquired NuCana in 2015 (active for 11 years).

Home/Companies/Biotech/NuCana

NuCana

Biotech·

UK·Active·11yr hold

NuCana is a healthcare / biotech company, headquartered in United Kingdom.

Entry

2015

Hold

11yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited Kingdom

SectorHealthcare / Biotech

UK oncology company using its ProTide technology platform to develop improved nucleotide analogs for cancer treatment.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

Corvidia Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings